Skip to main content
Premium Trial:

Request an Annual Quote

Gene Bridges Inks Genetic-Engineering Alliance With BASF

NEW YORK (GenomeWeb News) — Gene Bridges will use its recombination technology in collaboration with BASF in a genetic-engineering project using E. coli, Gene Bridges said Wednesday.
Under the agreement, Heidelberg, Germany-based Gene Bridges will use its Red/ET technology in bio-molecular engineering tasks, and BASF will perform screening and product and process development projects.
Gene Bridges said the agreement could “result in a significant acceleration” of development of particular E. coli strains.
Gene Bridges offers services, commercial licenses and kits using its recombineering technology.
The company’s Red/ET is an in vivo process that involved endogenous proofreading and repair mechanisms of bacterium cells, and is used in genetic engineering. It allows base specific insertion or excision of DNA fragments at selected points on the E. coli genome.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.